L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
47,450
-1,750 (-3.56%)
Sep 11, 2026, 3:30 PM KST

L&C BIO Co.,LTD Revenue

L&C BIO Co.,LTD had revenue of 38.79B KRW in the quarter ending June 30, 2026, with 88.45% growth. This brings the company's revenue in the last twelve months to 116.30B, up 53.20% year-over-year. In the year 2025, L&C BIO Co.,LTD had annual revenue of 85.48B with 18.66% growth.

Revenue (ttm)
116.30B
Revenue Growth
+53.20%
P/S Ratio
11.00
Revenue / Employee
676.19M
Employees
172
Market Cap
1.28T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202585.48B13.44B18.66%
Dec 31, 202472.03B6.11B9.26%
Dec 31, 202365.93B13.35B25.40%
Dec 31, 202252.57B6.90B15.10%
Dec 31, 202145.68B12.70B38.53%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
SD Biosensor738.76B
Seegene509.27B
CLASSYS369.11B
i-SENS326.19B
InBody Co.,Ltd263.89B
T&L Co., Ltd.175.16B
WON TECH167.35B
BioNote126.41B
Revenue Rankings

L&C BIO Co.,LTD News

More News